i - Search

Clinical Trials

• I PREVENT - Irbesartan In Hypertensive Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00362258 - Recruiting
  Hypertension
  
• I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00335673 - Active, not recruiting
  Hypertension
  
• I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy
  ClinicalTrials.gov Identifier: NCT00362037 - Recruiting
  Hypertension
  
• I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00001771 - Completed
  Healthy; Mental Disorder; Obsessive Compulsive Disorder; Schizophrenia; Tourette Syndrome
  
• I-125 Versus Pd-103 for Low Risk Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00494039 - Active, not recruiting
  Prostate Cancer
  
• I-125 Versus Pd-103 for Medium Risk Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00486499 - Recruiting
  Prostate Cancer
  
• I-STOP TOMS - Trans Obturator Male Sling
  ClinicalTrials.gov Identifier: NCT00442078 - Recruiting
  Male Urinary Incontinence
  
• I3LTE4: Intensive Insulin Therapy and Production of LTE4 in Patients With Diabetes
  ClinicalTrials.gov Identifier: NCT00324792 - Recruiting
  Diabetes Mellitus; Leucotrienes
  
• Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
  ClinicalTrials.gov Identifier: NCT00326820 - Recruiting
  Breast Cancer; Hypercalcemia; Metastatic Cancer
  
• Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation.
  ClinicalTrials.gov Identifier: NCT00423384 - Recruiting
  Renal Transplant
  
• Ibritumomab Tiuxetan + Rituximab Maintenance
  ClinicalTrials.gov Identifier: NCT00582166 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Ibritumomab Tiuxetan for Early Stage Indolent Lymphomas
  ClinicalTrials.gov Identifier: NCT00493467 - Recruiting
  Lymphoma
  
• Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas
  ClinicalTrials.gov Identifier: NCT00493454 - Active, not recruiting
  Lymphoma
  
• Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever
  ClinicalTrials.gov Identifier: NCT00267293 - Recruiting
  Fever
  
• Ibuprofen and Renal Function in Premature Infants
  ClinicalTrials.gov Identifier: NCT00217191 - Completed
  Premature Infants; Patent Ductus Arteriosus
  
• Ibuprofen in Sepsis Study
  ClinicalTrials.gov Identifier: NCT00000574 - Completed
  Acute Respiratory Distress Syndrome; Lung Diseases; Shock, Septic
  
• Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA
  ClinicalTrials.gov Identifier: NCT00485160 - Completed
  Patent Ductus Arteriosus
  
• Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial
  ClinicalTrials.gov Identifier: NCT00219700 - Active, not recruiting
  Osteoarthritis
  
• IC14 Antibodies to Treat Individuals With Acute Lung Injury
  ClinicalTrials.gov Identifier: NCT00233207 - Terminated
  Respiratory Distress Syndrome, Adult; Lung Diseases
  
• Ice Chips Or Saline Mouth Rinse in Reducing Or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00118339 - Completed
  oral complications of cancer and cancer therapy; Drug Toxicity; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• ICG Angiography in Amniotic Membrane Graft and Conjunctival Autograft After Pterygium Excision
  ClinicalTrials.gov Identifier: NCT00383825 - Completed
  Pterygium
  
• ICI 182780 in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00012025 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer
  ClinicalTrials.gov Identifier: NCT00010153 - Completed
  stage I breast cancer; stage II breast cancer
  
• ICIBS Trial - Improving Patient Information About Bowel Cancer Screening - a Decision Aid Trial
  ClinicalTrials.gov Identifier: NCT00148226 - Completed
  Colorectal Cancer Screening
  
• ICMR-Indiaclen Trial on Amoxycillin vs Cotrimoxazole for Non-Severe Pneumonia
  ClinicalTrials.gov Identifier: NCT00396526 - Completed
  Non-Severe Pneumonia; Under-Fives; Children
  
• ICP Versus Intracranial Compliance Guided Management in SAH
  ClinicalTrials.gov Identifier: NCT00248690 - Recruiting
  Subarachnoid Hemorrhage (SAH)
  
• ICP Waveform Analysis in Stroke Patients
  ClinicalTrials.gov Identifier: NCT00509119 - Recruiting
  Stroke
  
• ICTUS Study: International Citicoline Trial on acUte Stroke
  ClinicalTrials.gov Identifier: NCT00331890 - Recruiting
  Acute Stroke; Cerebral Infarction
  
• ICU (Intensive Care Unit)-Acquired Paresis and the Risk for Mortality and Recurrent ICU Admission
  ClinicalTrials.gov Identifier: NCT00106665 - Completed
  Muscle Weakness; Critical Illness
  
• ICU Nutrition Study Bern
  ClinicalTrials.gov Identifier: NCT00574431 - Not yet recruiting
  Critical Illness; Starvation; Enteral Nutrition
  
• ICU Turning RCT Pilot
  ClinicalTrials.gov Identifier: NCT00542321 - Recruiting
  Pneumonia, Ventilator-Associated
  
• ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients.
  ClinicalTrials.gov Identifier: NCT00396461 - Recruiting
  Critical Illness
  
• Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00096148 - Completed
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
  
• Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00528398 - Recruiting
  Leukemia
  
• Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00193973 - Active, not recruiting
  Primary Central Nervous System Lymphoma
  
• Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00077116 - Active, not recruiting
  adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes
  
• Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00096122 - Active, not recruiting
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
  
• IdB 1016 Treatment for Hepatitis C Disease
  ClinicalTrials.gov Identifier: NCT00055445 - Completed
  Hepatitis C, Chronic
  
• IDE Clinical Trial Comparing Coflex vs. Fusion to Treat Lumbar Spinal Stenosis
  ClinicalTrials.gov Identifier: NCT00534235 - Recruiting
  Lumbar Spinal Stenosis
  
• IDE Study for the Approval of CLS and CRT Pacing Therapies for the Treatment of AF With Ablate and Pace
  ClinicalTrials.gov Identifier: NCT00356057 - Recruiting
  Atrial Fibrillation; Congestive Heart Failure
  
• IDEA-033 Open Label Study
  ClinicalTrials.gov Identifier: NCT00372333 - Active, not recruiting
  Joint Pain; Musculoskeletal Pain; Stiffness; Soft Tissue Inflammation in Designated Target Area(s)
  
• IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA
  ClinicalTrials.gov Identifier: NCT00316784 - Completed
  Osteoarthritis; Knee
  
• Ideal Dose of Phenylephrine to Treat Low Blood Pressure During Cesarean Section
  ClinicalTrials.gov Identifier: NCT00379691 - Completed
  Hypotension; Nausea
  
• IDEAL Study
  ClinicalTrials.gov Identifier: NCT00128518 - Recruiting
  Hypertension
  
• Idebenone to Treat Friedreich's Ataxia
  ClinicalTrials.gov Identifier: NCT00229632 - Active, not recruiting
  Friedreich Ataxia
  
• Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00223483 - Recruiting
  Hematologic Diseases; Healthy Volunteers
  
• Identification and Characterization of Novel Proteins in Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00230308 - Recruiting
  Head and Neck Cancer
  
• Identification and Impact of Vaginal Flora Anomalies Among Pregnant Woman
  ClinicalTrials.gov Identifier: NCT00484653 - Recruiting
  Vaginosis, Bacterial
  
• Identification and therapy efficacy of Type 2 diabetes in Hispanic patients
  ClinicalTrials.gov Identifier: NCT00004572 - Active, not recruiting
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Identification and Therapy of Postpartum Depression
  ClinicalTrials.gov Identifier: NCT00282776 - Recruiting
  Depression
  
• Identification and Treatment of Feeder Vessels in Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00018070 - Completed
  Macular Degeneration
  
• Identification and Treatment of Men With BPH in the Primary Care Setting
  ClinicalTrials.gov Identifier: NCT00211640 - Completed
  No Conditions for This Study. All Male Patients 18 Years of Age or Older Were Administered the LUTS, MSHQ, and Patient Demographics Questionnaire
  
• Identification and Treatment of the Liability to Develop Schizophrenia
  ClinicalTrials.gov Identifier: NCT00305474 - Recruiting
  Schizophrenia
  
• Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer Study
  ClinicalTrials.gov Identifier: NCT00282529 - Recruiting
  Breast Cancer; Lymphedema
  
• Identification of an Asthma Susceptibility Gene on 3P
  ClinicalTrials.gov Identifier: NCT00006510 - Active, not recruiting
  Asthma; Lung Diseases
  
• Identification of Biomarkers Associated with Human Hepatocellular Carcinoma by SELDI
  ClinicalTrials.gov Identifier: NCT00154531 - Recruiting
  Hepatocellular Carcinoma; Hepatitis B; Hepatitis C
  
• Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients
  ClinicalTrials.gov Identifier: NCT00568282 - Recruiting
  Lung Cancer
  
• Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
  ClinicalTrials.gov Identifier: NCT00330109 - Recruiting
  Glioma
  
• Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis
  ClinicalTrials.gov Identifier: NCT00285441 - Recruiting
  Tuberculosis; HIV Infections; Rheumatoid Arthritis
  
• Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus
  ClinicalTrials.gov Identifier: NCT00015639 - Completed
  Thrombocytopenia
  
• Identification of Gene Polymorphism in Patients With Sick Sinus Syndrome in Chinese Population in Taiwan
  ClinicalTrials.gov Identifier: NCT00314223 - Recruiting
  Sinus Arrhythmia
  
• Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
  ClinicalTrials.gov Identifier: NCT00003329 - Recruiting
  Breast Cancer; Colorectal Cancer; Lung Cancer; Prostate Cancer
  
• Identification of Genes Associated with Lung Disease in Patients with Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00001885 - Recruiting
  Healthy; Pulmonary Fibrosis; Rheumatoid Arthritis
  
• Identification of Genes Expressed in Atherosclerotic Plaque
  ClinicalTrials.gov Identifier: NCT00353730 - Active, not recruiting
  Atherosclerosis
  
• Identification of Genes Predisposing to Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00059098 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Heart Diseases
  
• Identification of Hepatic Lesions
  ClinicalTrials.gov Identifier: NCT00307866 - Completed
  Hepatic Neoplasms
  
• Identification of Key Blood Molecular Markers for Immunotherapy
  ClinicalTrials.gov Identifier: NCT00507702 - Recruiting
  Cancer
  
• Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00373347 - Recruiting
  Liver Cancer; Hepatic Cancer
  
• Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data
  ClinicalTrials.gov Identifier: NCT00578409 - Recruiting
  Prostate Cancer
  
• Identification of Prostate Cancer Genes
  ClinicalTrials.gov Identifier: NCT00342784 - Active, not recruiting
  Prostate Cancer
  
• Identification of Risk Allels for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00323388 - Active, not recruiting
  Prostate Cancer
  
• Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope
  ClinicalTrials.gov Identifier: NCT00314405 - Recruiting
  Infiltrative Breast Cancer
  
• Identification of Serum Markers for Tumor Hypoxia in Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00185822 - Recruiting
  Lip Cancer; Oral Cancer; Pharynx Cancer
  
• Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
  ClinicalTrials.gov Identifier: NCT00185913 - Active, not recruiting
  Carcinoma, Non-Small Cell Lung
  
• Identification of Serum Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancer
  ClinicalTrials.gov Identifier: NCT00568490 - Recruiting
  Head and Neck Cancer; Lung Cancer
  
• Identification of Sleep-Disordered Breathing in Children
  ClinicalTrials.gov Identifier: NCT00233194 - Recruiting
  Sleep; Sleep Apnea Syndromes
  
• Identification of the Cranberry Juice Compounds that Prevent Urinary Tract Infections
  ClinicalTrials.gov Identifier: NCT00087828 - Completed
  Urinary Tract Infections
  
• Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)
  ClinicalTrials.gov Identifier: NCT00145964 - Recruiting
  Liver Cirrhosis, Biliary; Biliary Cirrhosis, Primary
  
• Identification of Viruses Associated With Diseases of Unknown Cause
  ClinicalTrials.gov Identifier: NCT00359268 - Recruiting
  Viral Diseases
  
• Identifying Characteristics of Bone Marrow Failure Syndromes
  ClinicalTrials.gov Identifier: NCT00315419 - Recruiting
  Bone Marrow Failure Syndromes; Anemia, Aplastic; Myelodysplastic Syndromes; Hemoglobinuria, Paroxysmal; Red-Cell Aplasia, Pure; Purpura, Thrombocytopenic; Leukemia, Lymphocytic
  
• Identifying Emergency Room Patients Who Have Recently Been Infected with HIV
  ClinicalTrials.gov Identifier: NCT00001130 - Completed
  HIV Infections
  
• Identifying Factors That Predict Antidepressant Treatment Response
  ClinicalTrials.gov Identifier: NCT00360399 - Recruiting
  Depression
  
• Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
  ClinicalTrials.gov Identifier: NCT00450593 - Recruiting
  Hereditary Melanoma 1 and 2 (cdkn2, cdk4); Melanoma (Skin)
  
• Identifying Genes Involved in Abnormal Blood Pressure - Hypertension SCOR
  ClinicalTrials.gov Identifier: NCT00005325 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Identifying Genes That May Increase the Risk for Heart Disease in African Americans
  ClinicalTrials.gov Identifier: NCT00344136 - Completed
  Heart Diseases
  
• Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00458562 - Recruiting
  Cervical Cancer; Precancerous/Nonmalignant Condition
  
• Identifying Genetic Characteristics That Increase the Risk of Developing Primary Graft Dysfunction Following Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00457847 - Recruiting
  Primary Graft Dysfunction; Lung Transplantation
  
• Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00515047 - Recruiting
  Atopic Dermatitis
  
• Identifying Genetic Markers for Esophageal Cancer and Stomach Cancer in Chinese Populations
  ClinicalTrials.gov Identifier: NCT00558415 - Recruiting
  Esophageal Cancer; Gastric Cancer
  
• Identifying High Risk Patients With Syncope
  ClinicalTrials.gov Identifier: NCT00005202 - Completed
  Cardiovascular Diseases; Arrhythmia; Death, Sudden, Cardiac; Heart Diseases; Syncope
  
• Identifying High- and Low-Risk Heart Failure Patients in the Emergency Department (The Stratify Study)
  ClinicalTrials.gov Identifier: NCT00508638 - Recruiting
  Cardiovascular Diseases
  
• Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00394940 - Active, not recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Identifying Low-Risk Patients with Pulmonary Embolism
  ClinicalTrials.gov Identifier: NCT00086151 - Active, not recruiting
  Pulmonary Embolism; Lung Diseases
  
• Identifying Methylation Biomarkers for Monitoring Bladder Tumors
  ClinicalTrials.gov Identifier: NCT00244205 - Recruiting
  Bladder Cancer
  
• Identifying New Families With Multiple Members Affected by Chordoma
  ClinicalTrials.gov Identifier: NCT00558714 - Recruiting
  Chordoma
  
• Identifying Patients With Dementia in Primary Care
  ClinicalTrials.gov Identifier: NCT00289471 - Recruiting
  Dementia; Memory Disorders
  
• Identifying Residential Hazards Using Home Test Kits
  ClinicalTrials.gov Identifier: NCT00285532 - Recruiting
  Lead Poisoning
  
• Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00438022 - Recruiting
  Atopic Dermatitis; Eczema Herpeticum
  
• Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and Sarcoidosis
  ClinicalTrials.gov Identifier: NCT00560989 - Completed
  Sarcoidosis; Berylliosis
  
• Identifying the Anti-Blood-Clotting Compounds in Garlic
  ClinicalTrials.gov Identifier: NCT00200785 - Completed
  Arteriosclerosis; Intracranial Arteriosclerosis
  
• Identifying the Relative Change in Ventilation in Newborns With Placement in Car Bed or Car Seat
  ClinicalTrials.gov Identifier: NCT00382876 - Recruiting
  Apnea
  
• Identifying the Role of Oxytocin and Vasopressin in the Functioning of Neurocognitive Systems Involved in Mood Disorders
  ClinicalTrials.gov Identifier: NCT00325065 - Recruiting
  Mood Disorders
  
• Identifying Vulnerable Plaques in Blood Vessels of the Heart Using a New Imaging Technique
  ClinicalTrials.gov Identifier: NCT00540761 - Recruiting
  Coronary Arteriosclerosis
  
• Identity Development and HIV Risk in Gay/Bisexual/Questioning Male Youth
  ClinicalTrials.gov Identifier: NCT00103441 - Recruiting
  Healthy; Risk Behavior; HIV Infections
  
• Idiopathic Anemia of Aging (IAA)
  ClinicalTrials.gov Identifier: NCT00104169 - Active, not recruiting
  Anemia; Aging
  
• Idiopathic Dilated Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00005201 - Completed
  Heart Diseases; Cardiomyopathy, Congestive
  
• Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00063869 - Active, not recruiting
  Pulmonary Fibrosis
  
• Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases
  ClinicalTrials.gov Identifier: NCT00005317 - Completed
  Lung Diseases; Pulmonary Fibrosis; Lung Diseases, Interstitial; Scleroderma, Systemic
  
• Idiopathic Pulmonary Fibrosis: a Case-control Study
  ClinicalTrials.gov Identifier: NCT00005295 - Completed
  Lung Diseases; Pulmonary Fibrosis; Lung Diseases, Interstitial
  
• Idiotype Vaccine Following High-Dose Chemotherapy and Hematopoietic Stem Cell Transplantation for Patients With Lymphoma Who Had Failed Induction Chemotherapy
  ClinicalTrials.gov Identifier: NCT00574886 - Active, not recruiting
  Lymphoma
  
• Idiotype Vaccine for Low-grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00036426 - Active, not recruiting
  Lymphoma, Low-Grade
  
• Idiotypic Vaccination for Follicular Lymphoma Patients
  ClinicalTrials.gov Identifier: NCT00530140 - Recruiting
  Follicular Lymphoma; First Relapse/Progression
  
• Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)
  ClinicalTrials.gov Identifier: NCT00069641 - Completed
  Mucopolysaccharidosis II
  
• IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00300586 - Recruiting
  Stage IV Non-Small Cell Lung Cancer
  
• IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00200681 - Recruiting
  Multiple Myeloma
  
• IFM 99-02 Thalidomide in Myeloma
  ClinicalTrials.gov Identifier: NCT00222053 - Active, not recruiting
  Multiple Myeloma
  
• IFN/RBV for Prevention of HCC Recurrence
  ClinicalTrials.gov Identifier: NCT00375661 - Recruiting
  Hepatitis C, Chronic
  
• Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00484601 - Recruiting
  Refractory Nasopharyngeal Carcinoma
  
• Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00334854 - Recruiting
  Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma
  
• Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003198 - Completed
  unspecified adult solid tumor, protocol specific
  
• Ifosfamide in Treating Patients With Meningeal Tumors
  ClinicalTrials.gov Identifier: NCT00003292 - Suspended
  Chondrosarcoma; adult fibrosarcoma; adult leiomyosarcoma; adult rhabdomyosarcoma; adult malignant meningioma; ...
  
• Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00003212 - Active, not recruiting
  Soft Tissue Sarcoma; Uterine Cancer
  
• Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00086970 - Completed
  unspecified adult solid tumor, protocol specific
  
• Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00003128 - Active, not recruiting
  stage III uterine sarcoma; stage IV uterine sarcoma; recurrent uterine sarcoma; uterine carcinosarcoma
  
• Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00354107 - Suspended
  Lymphoma
  
• Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004916 - Active, not recruiting
  recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; ...
  
• Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00193505 - Active, not recruiting
  Non-Hodgkins Lymphoma
  
• Ig NextGen 10% in ITP Patients
  ClinicalTrials.gov Identifier: NCT00362349 - Recruiting
  Idiopathic Thrombocytopenic Purpura (ITP)
  
• Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)
  ClinicalTrials.gov Identifier: NCT00405184 - Recruiting
  Primary Immune Deficiency (PID)
  
• IGF-1 Therapy in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00566241 - Recruiting
  Cystic Fibrosis
  
• IGF-1/ALS Trial
  ClinicalTrials.gov Identifier: NCT00035815 - Completed
  Amyotrophic Lateral Sclerosis
  
• IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome
  ClinicalTrials.gov Identifier: NCT00368173 - Active, not recruiting
  Growth Hormone Insensitivity Syndrome (GHIS); Laron Syndrome
  
• IGF1 Generation Test
  ClinicalTrials.gov Identifier: NCT00145457 - Completed
  Growth Hormone Deficiency
  
• IGFBP-3 in Ovarian Cancer Invasion
  ClinicalTrials.gov Identifier: NCT00154986 - Recruiting
  Ovarian Carcinoma
  
• IGIV Study for Chronic ITP Patients Ages 3-70
  ClinicalTrials.gov Identifier: NCT00511147 - Not yet recruiting
  Idiopathic Thrombocytopenic Purpura
  
• IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer
  ClinicalTrials.gov Identifier: NCT00100893 - Recruiting
  Breast Cancer
  
• IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer
  ClinicalTrials.gov Identifier: NCT00041223 - Active, not recruiting
  Radiation Fibrosis; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• IL 6 Measurement Using a New Densitometric Bedside (POC) Test
  ClinicalTrials.gov Identifier: NCT00525369 - Completed
  Sepsis, Septic Shock
  
• IL-1 Trap for Treatment of CIAS1 Associated Periodic Syndromes (CAPS)
  ClinicalTrials.gov Identifier: NCT00288704 - Active, not recruiting
  Familial Cold Autoinflammatory Syndrome; Familial Cold Urticaria; Muckle-Wells Syndrome; Genetic Diseases, Inborn
  
• IL-1 Trap for Treatment of Familial Mediterranean Fever (FMF)
  ClinicalTrials.gov Identifier: NCT00582907 - Not yet recruiting
  Familial Mediterranean Fever
  
• IL-11 in Adults With Von Willebrand Disease Undergoing Surgery
  ClinicalTrials.gov Identifier: NCT00524225 - Recruiting
  Von Willebrand Disease
  
• IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia
  ClinicalTrials.gov Identifier: NCT00524342 - Recruiting
  Von Willebrand Disease
  
• IL-2 Gene Therapy for Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00059163 - Recruiting
  Melanoma
  
• IL-2 Therapy in Lymphodepleted Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00225771 - Active, not recruiting
  Metastatic Melanoma
  
• IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma
  ClinicalTrials.gov Identifier: NCT00003842 - Active, not recruiting
  adult glioblastoma multiforme; adult anaplastic astrocytoma; recurrent adult brain tumor
  
• IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00089427 - Active, not recruiting
  Glioblastoma Multiforme; Anaplastic Astrocytoma; Oligoastrocytoma
  
• ILF With/Without Cisplatin for Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00320294 - Active, not recruiting
  Stomach Neoplasm
  
• Ilioinguinal Nerve Excision in Open Mesh Repair of Inguinal Hernia,a Randomized Clinical Trial
  ClinicalTrials.gov Identifier: NCT00500214 - Completed
  Postoperative Pain; Postoperative Hyposthesia
  
• Illinois WISEWOMAN Project
  ClinicalTrials.gov Identifier: NCT00153387 - Completed
  CVD risk
  
• Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention
  ClinicalTrials.gov Identifier: NCT00345501 - Completed
  Renal Insufficiency, Chronic; Coronary Angiography; Angioplasty, Transluminal, Percutaneous Coronary
  
• Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
  ClinicalTrials.gov Identifier: NCT00084409 - Recruiting
  Non-small cell lung cancer; Small Cell Lung Cancer
  
• Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery
  ClinicalTrials.gov Identifier: NCT00235521 - Recruiting
  Pulmonary Hypertension
  
• ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00005645 - Active, not recruiting
  recurrent ovarian epithelial cancer; malignant ascites; peritoneal cavity cancer; liver metastases; Fallopian Tube Cancer; Malignant Pleural Effusion; ...
  
• ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00004926 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)
  ClinicalTrials.gov Identifier: NCT00136994 - Completed
  Schizophrenia
  
• IM-862 in Treating Patients With AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00003879 - Completed
  epidemic Kaposi's sarcoma; recurrent Kaposi's sarcoma; Quality of Life
  
• IM-862 in Treating Patients With Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003773 - Active, not recruiting
  recurrent ovarian epithelial cancer
  
• IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease
  ClinicalTrials.gov Identifier: NCT00523159 - Recruiting
  Renal Cell Carcinoma
  
• Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute
  ClinicalTrials.gov Identifier: NCT00314470 - Recruiting
  Healthy
  
• Image Fusion PET, CT and 3D-Ultrasound Examinations
  ClinicalTrials.gov Identifier: NCT00302094 - Recruiting
  Anal Cancer
  
• Image Guided Radiation Therapy For Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00433706 - Recruiting
  Prostate Cancer
  
• Image Guided System for Orthopaedic Surgery
  ClinicalTrials.gov Identifier: NCT00022802 - Terminated
  Orthopaedic trauma; Hip Fracture
  
• IMAGE-Endocarditis
  ClinicalTrials.gov Identifier: NCT00144885 - Recruiting
  Endocarditis, Bacterial
  
• Image-Guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
  ClinicalTrials.gov Identifier: NCT00571415 - Not yet recruiting
  Cervix Cancer
  
• IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-Based Surveillance for Heart Transplant Rejection
  ClinicalTrials.gov Identifier: NCT00351559 - Recruiting
  Graft Rejection; Heart Diseases
  
• Images in Extracranial Artery Stenosis
  ClinicalTrials.gov Identifier: NCT00173927 - Recruiting
  Extracranial Atherosclerosis
  
• Images of a Healthy Worksite
  ClinicalTrials.gov Identifier: NCT00123513 - Recruiting
  Obesity; Cardiovascular Diseases
  
• Imaging Ahmed Glaucoma Tubes With a Pericardial Graft and Tissue Glue or Partial-Thickness Scleral Flap and Sutures
  ClinicalTrials.gov Identifier: NCT00453024 - Recruiting
  Advanced Glaucoma; Failed Trabeculectomies
  
• Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-Risk Families
  ClinicalTrials.gov Identifier: NCT00273351 - Recruiting
  Parkinson Disease; Parkinsonian Syndrome
  
• Imaging Characteristics of Breast Cancer in Women Under 40 Years of Age
  ClinicalTrials.gov Identifier: NCT00155038 - Recruiting
  Breast Cancer; Breast Neoplasms
  
• Imaging Colo-Rectal Cancer Using a Two Step Antibody Technique in Nuclear Imaging
  ClinicalTrials.gov Identifier: NCT00185081 - Recruiting
  Colonic Neoplasms
  
• Imaging of Brain Receptors in Healthy Volunteers and in Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00061789 - Completed
  Schizophrenia
  
• Imaging of Cannabinoid Receptors Using New Radioactive Tracer
  ClinicalTrials.gov Identifier: NCT00450021 - Recruiting
  Healthy
  
• Imaging of Islet Transplantation With PET and MRT
  ClinicalTrials.gov Identifier: NCT00417131 - Recruiting
  Islet Transplantation
  
• Imaging of Plaque with Magnetic Resonance Imaging (MRI)
  ClinicalTrials.gov Identifier: NCT00115856 - Active, not recruiting
  Arterial Occlusive Disease
  
• Imaging of Totally Blocked Arteries
  ClinicalTrials.gov Identifier: NCT00459446 - Recruiting
  Atherosclerosis; Peripheral Artery Disease; Intermittent Claudication; Chronic Total Aterial Occlusion
  
• Imaging of Vulnerable Plaques in Coronary Artery Disease by Multidetector Computed Tomography
  ClinicalTrials.gov Identifier: NCT00482651 - Not yet recruiting
  Atherosclerosis
  
• Imaging Predictors of Treatment Response in Depression
  ClinicalTrials.gov Identifier: NCT00367341 - Recruiting
  Major Depressive Disorder
  
• Imaging Procedures in Women With a Genetic Risk For Breast Cancer
  ClinicalTrials.gov Identifier: NCT00012415 - Active, not recruiting
  Breast Cancer; Hereditary Breast/Ovarian Cancer (brca1, brca2)
  
• Imaging Studies With GE C-Hawk Gamma Camera Compared to Routine Clinical Exam
  ClinicalTrials.gov Identifier: NCT00256581 - Recruiting
  Coronary Artery Disease; Chest Pain
  
• Imaging Study in Patients With Known Head and Neck Cancer, Lung Cancer, Lymphoma, or Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00323076 - Recruiting
  Head and Neck Neoplasms; Lung Neoplasms; Lymphoma, Malignant; Glioblastoma Multiforme
  
• Imaging Study of Automatic Movements
  ClinicalTrials.gov Identifier: NCT00031382 - Completed
  Healthy
  
• Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication
  ClinicalTrials.gov Identifier: NCT00388414 - Recruiting
  Back Pain Without Radiation; Low Back Pain
  
• Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients with Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00064779 - Active, not recruiting
  Malignant Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Mixed Oligoastrocytoma
  
• Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk
  ClinicalTrials.gov Identifier: NCT00181233 - Recruiting
  Sudden Cardiac Death
  
• Imaging Techniques in Body MRI
  ClinicalTrials.gov Identifier: NCT00362557 - Recruiting
  Clinically Indicated MR Imaging
  
• Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence
  ClinicalTrials.gov Identifier: NCT00376558 - Recruiting
  Cocaine Dependence
  
• Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution
  ClinicalTrials.gov Identifier: NCT00260767 - Not yet recruiting
  HIV
  
• Imatinib (Gleevec® (Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00076297 - Recruiting
  
  
• Imatinib in Adult Patients With Metastatic Ocular Melanoma
  ClinicalTrials.gov Identifier: NCT00421317 - Recruiting
  Melanoma
  
• Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
  ClinicalTrials.gov Identifier: NCT00354523 - Active, not recruiting
  Solid Tumor; Thyroid Cancer
  
• Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma
  ClinicalTrials.gov Identifier: NCT00424515 - Recruiting
  Mucosal Melanoma; Acral/Lentiginous Melanoma
  
• Imatinib in Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00506831 - Recruiting
  Scleroderma, Systemic
  
• Imatinib Mesylate (Gleevec; STI571) in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00041197 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia
  ClinicalTrials.gov Identifier: NCT00244829 - Completed
  Leukemia
  
• Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00248482 - Active, not recruiting
  Lung Cancer
  
• Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00066326 - Completed
  blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
  
• Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00425646 - Recruiting
  Lung Cancer
  
• Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers
  ClinicalTrials.gov Identifier: NCT00074308 - Recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma; unspecified adult solid tumor, protocol specific
  
• Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00253565 - Completed
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00087152 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00045604 - Completed
  extensive stage small cell lung cancer
  
• Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00028847 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00054431 - Completed
  accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; ...
  
• Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00281996 - Completed
  Pancreatic Cancer
  
• Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
  ClinicalTrials.gov Identifier: NCT00354913 - Recruiting
  Brain and Central Nervous System Tumors
  
• Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00015847 - Completed
  relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00408460 - Recruiting
  Lung Cancer
  
• Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors
  ClinicalTrials.gov Identifier: NCT00573404 - Recruiting
  Gastrointestinal Stromal Tumor
  
• Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00354068 - Recruiting
  Brain and Central Nervous System Tumors
  
• Imatinib Mesylate and Zoledronic Acid in Patients with Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response
  ClinicalTrials.gov Identifier: NCT00210119 - Terminated
  Myeloid Leukemia, Chronic
  
• Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00403156 - Recruiting
  Choroidal Neovascularization
  
• Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00216112 - Completed
  Ovarian Cancer
  
• Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors
  ClinicalTrials.gov Identifier: NCT00417807 - Recruiting
  Refractory Desmoplastic Small Round Cell Tumors
  
• Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
  ClinicalTrials.gov Identifier: NCT00171912 - Recruiting
  Hypereosinophilic Syndrome; Systemic Mastocytosis; Chronic Myelomonocytic Leukemia; Dermatofibrosarcoma
  
• Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure
  ClinicalTrials.gov Identifier: NCT00026169 - Completed
  adult solid tumor; central nervous system cancer; Gastrointestinal Cancer; hematopoietic and lymphoid cancer
  
• Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction
  ClinicalTrials.gov Identifier: NCT00025415 - Completed
  adult solid tumor; Gastrointestinal Cancer; hematopoietic and lymphoid cancer
  
• Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma
  ClinicalTrials.gov Identifier: NCT00031915 - Completed
  Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; Osteosarcoma
  
• Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00030394 - Completed
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; childhood chronic myelogenous leukemia
  
• Imatinib Mesylate in Treating Patients With Chronic Myelomonocytic Leukemia or Atypical Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00079313 - Recruiting
  Leukemia
  
• Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00070499 - Recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00025246 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Imatinib Mesylate in Treating Patients With Gliomas
  ClinicalTrials.gov Identifier: NCT00039364 - Active, not recruiting
  adult brain tumor
  
• Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00090987 - Active, not recruiting
  epidemic Kaposi's sarcoma; recurrent Kaposi's sarcoma
  
• Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00112632 - Recruiting
  gastrointestinal stromal tumor
  
• Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma
  ClinicalTrials.gov Identifier: NCT00085475 - Active, not recruiting
  recurrent adult soft tissue sarcoma; stage III adult soft tissue sarcoma; stage IV adult soft tissue sarcoma; adult fibrosarcoma; ...
  
• Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans (DFSP) or Transformed Fibrosarcomatous DFSP
  ClinicalTrials.gov Identifier: NCT00084630 - Active, not recruiting
  adult fibrosarcoma; recurrent adult soft tissue sarcoma; stage III adult soft tissue sarcoma; adult malignant fibrous histiocytoma; ...
  
• Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00045188 - Completed
  Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
  
• Imatinib Mesylate in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00027586 - Suspended
  Stage IV Melanoma; Recurrent Melanoma
  
• Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
  ClinicalTrials.gov Identifier: NCT00068783 - Suspended
  stage III Merkel cell carcinoma; recurrent Merkel cell carcinoma; stage II Merkel cell carcinoma
  
• Imatinib Mesylate in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00039416 - Active, not recruiting
  Polycythemia Vera; chronic idiopathic myelofibrosis; Essential Thrombocythemia; Chronic Myelomonocytic Leukemia
  
• Imatinib Mesylate in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00245128 - Active, not recruiting
  Chronic Myeloproliferative Disorders
  
• Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy
  ClinicalTrials.gov Identifier: NCT00509093 - Recruiting
  Leukemia
  
• Imatinib Mesylate in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00324636 - Active, not recruiting
  Leukemia
  
• Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00041041 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00042952 - Completed
  ovarian germ cell tumor; Testicular Cancer
  
• Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
  ClinicalTrials.gov Identifier: NCT00049127 - Recruiting
  adult anaplastic oligodendroglioma; recurrent adult brain tumor; Mixed Gliomas; Adult Oligodendroglioma
  
• Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor
  ClinicalTrials.gov Identifier: NCT00062205 - Active, not recruiting
  recurrent tumors of the Ewing's family
  
• Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
  ClinicalTrials.gov Identifier: NCT00010049 - Completed
  adult brain tumor
  
• Imatinib Mesylate in Treating Patients With Recurrent Meningioma
  ClinicalTrials.gov Identifier: NCT00045734 - Completed
  adult meningioma; recurrent adult brain tumor; grade III meningioma; grade I meningioma; grade II meningioma; adult meningeal hemangiopericytoma
  
• Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Carcinosarcoma
  ClinicalTrials.gov Identifier: NCT00075400 - Active, not recruiting
  uterine carcinosarcoma; recurrent uterine sarcoma
  
• Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
  ClinicalTrials.gov Identifier: NCT00287846 - Recruiting
  Desmoid Tumor
  
• Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00052949 - Completed
  Recurrent Small Cell Lung Cancer
  
• Imatinib Mesylate in Treating Patients With Refractory Metastatic and/or Unresectable Stomach or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00068380 - Active, not recruiting
  recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; stage IV esophageal cancer; stage III esophageal cancer; ...
  
• Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor
  ClinicalTrials.gov Identifier: NCT00039585 - Completed
  recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer; ovarian low malignant potential tumor
  
• Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood
  ClinicalTrials.gov Identifier: NCT00030667 - Active, not recruiting
  Ewing's family of tumors; childhood soft tissue sarcoma; Gastrointestinal Cancer; metastatic cancer; Neuroblastoma; Osteosarcoma
  
• Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
  ClinicalTrials.gov Identifier: NCT00045669 - Active, not recruiting
  recurrent salivary gland cancer; salivary gland adenoid cystic carcinoma; stage III salivary gland cancer; stage IV salivary gland cancer
  
• Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00470470 - Recruiting
  Melanoma (Skin)
  
• Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00036751 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00041340 - Completed
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00103168 - Recruiting
  gastrointestinal stromal tumor
  
• Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00022490 - Completed
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Imatinib Mesylate to Treat Myeloproliferative Hypereosinophilic Syndrome
  ClinicalTrials.gov Identifier: NCT00044304 - Recruiting
  Hypereosinophilic Syndrome
  
• Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors
  ClinicalTrials.gov Identifier: NCT00427583 - Recruiting
  Malignant Peripheral Nerve Sheath Tumors
  
• Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00324987 - Not yet recruiting
  Gastrointestinal Stromal Tumor
  
• Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Allogeneic Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00055874 - Recruiting
  chronic phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia
  
• Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma
  ClinicalTrials.gov Identifier: NCT00021229 - Active, not recruiting
  childhood central nervous system germ cell tumor; high-grade childhood cerebral astrocytoma; untreated childhood brain stem glioma; ...
  
• Imatinib Mesylate, Bevacizumab, and Cyclophosphamide in Treating Patients With Refractory Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00390156 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Imatinib Mesylate, Busulfan, Fludarabine, and ATG for CML Patients
  ClinicalTrials.gov Identifier: NCT00499889 - Recruiting
  Leukemia
  
• Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00268229 - Recruiting
  Leukemia
  
• Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00483366 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Imatinib Mesylate, Interferon Alfa, and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00363649 - Recruiting
  Leukemia
  
• Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00387933 - Recruiting
  Brain and Central Nervous System Tumors
  
• Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)
  ClinicalTrials.gov Identifier: NCT00514488 - Completed
  Chronic Myeloid Leukemia
  
• Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy
  ClinicalTrials.gov Identifier: NCT00297570 - Recruiting
  Leukemia, Myeloid, Philadelphia-Positive
  
• Imiquimod 5% Cream in Plaque-Type Morphea: A Pilot, Prospective Open-Label Study
  ClinicalTrials.gov Identifier: NCT00230373 - Active, not recruiting
  Morphea
  
• Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin
  ClinicalTrials.gov Identifier: NCT00453050 - Recruiting
  Melanoma (Skin); Metastatic Cancer
  
• Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer
  ClinicalTrials.gov Identifier: NCT00079300 - Active, not recruiting
  Non-Melanomatous Skin Cancer
  
• Imiquimod in Children with Plaque Morphea
  ClinicalTrials.gov Identifier: NCT00147771 - Recruiting
  Morphea (localized scleroderma)
  
• Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia
  ClinicalTrials.gov Identifier: NCT00031759 - Active, not recruiting
  Cervical Cancer
  
• Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00257530 - Not yet recruiting
  Cutaneous Leishmaniasis
  
• IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency
  ClinicalTrials.gov Identifier: NCT00228852 - Recruiting
  T-Cell Immune Deficiency Diseases; Severe Combined Immunodeficiency
  
• Immediate Compared With Delayed Chemotherapy in Treating Patients With Advanced Colorectal Cancer Without Signs or Symptoms of Disease
  ClinicalTrials.gov Identifier: NCT00002570 - Active, not recruiting
  recurrent colon cancer; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)
  ClinicalTrials.gov Identifier: NCT00413829 - Completed
  Age Related Macular Degeneration
  
• Immediate Implant Placement in the Molar Regions
  ClinicalTrials.gov Identifier: NCT00226148 - Active, not recruiting
  Periodontitis; Dental Caries; Periapical Periodontitis
  
• Immediate Load of Dental Implants, Placed in Atrophic Upper and/or Lower Jaw of Partial or Complete Edentate Patients, According to Flapless Technique
  ClinicalTrials.gov Identifier: NCT00136123 - Recruiting
  Dental Implantation
  
• Immediate Loading of Implants in Totally Edentate Upper and Lower Jaw. A Retrospective Trial to Evaluate Survival of the Implants and Bridges, Quality of Prothetic Work and Patient Satisfaction
  ClinicalTrials.gov Identifier: NCT00147992 - Recruiting
  Dental Implants
  
• Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00287196 - Recruiting
  Malignant Melanoma; Lymph Node Disease
  
• Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00206128 - Completed
  Schizophrenia
  
• Immediate Treatment Vs Colposcopic Follow-Up for Biopsy-Proven CIN 1
  ClinicalTrials.gov Identifier: NCT00156026 - Completed
  Cervical Intraepithelial Neoplasia
  
• IMMEDIATE Trial: Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency care Trial
  ClinicalTrials.gov Identifier: NCT00091507 - Recruiting
  Angina, Unstable; Cardiovascular Diseases; Heart Diseases; Coronary Disease; Myocardial Infarction; Heart Failure
  
• Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis
  ClinicalTrials.gov Identifier: NCT00433719 - Recruiting
  HIV Infections; Tuberculous Meningitis
  
• Immediate Versus Deferred Start of Anti-HIV Therapy in HIV Infected Adults Being Treated for Tuberculosis
  ClinicalTrials.gov Identifier: NCT00108862 - Recruiting
  HIV Infections; Tuberculosis
  
• Immediate Versus Delayed IUD Insertion Following First Trimester Suction Aspiration Procedures
  ClinicalTrials.gov Identifier: NCT00562276 - Recruiting
  Contraception
  
• Immediate vs Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy.
  ClinicalTrials.gov Identifier: NCT00439751 - Recruiting
  Prostate Cancer
  
• Immediate Vs. Deferred Empirical Antifungal Treatment with Voriconazole
  ClinicalTrials.gov Identifier: NCT00150345 - Recruiting
  Neutropenia
  
• Immediate vs. Delayed Insertion of Copper T 380A IUD After Termination of Pregnancy Over 12-Weeks Gestation
  ClinicalTrials.gov Identifier: NCT00540046 - Recruiting
  Contraception Compliance
  
• Immobilization in External Rotation of Acute Shoulder Dislocations
  ClinicalTrials.gov Identifier: NCT00196560 - Active, not recruiting
  Anterior Shoulder Dislocation
  
• Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study
  ClinicalTrials.gov Identifier: NCT00271934 - Completed
  Systemic Lupus Erythematosus
  
• Immune Ablation and Stem Cell Support for Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00179842 - Recruiting
  Crohn Disease
  
• Immune Abnormalities in Sporadic Inclusion Body Myositis
  ClinicalTrials.gov Identifier: NCT00030212 - Completed
  Sporadic; Inclusion Body; Myositis
  
• Immune Activity Against CVM Retinitis
  ClinicalTrials.gov Identifier: NCT00001611 - Completed
  Acquired Immunodeficiency Syndrome; Cytomegalovirus Retinitis; HIV Infection
  
• Immune and Endocrine Function in Post-traumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00100490 - Completed
  Post-Traumatic Stress Disorders
  
• Immune and Viral Outcomes of HIV-1 Therapy Interruption
  ClinicalTrials.gov Identifier: NCT00051818 - Completed
  HIV Infections
  
• Immune and Viral Status of HIV-Infected Patients after Stopping Combination Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00001899 - Active, not recruiting
  HIV Infection
  
• Immune Cell Response to Stimuli
  ClinicalTrials.gov Identifier: NCT00397280 - Not yet recruiting
  Healthy
  
• Immune Dysfunction in Allergic Asthma
  ClinicalTrials.gov Identifier: NCT00189228 - Recruiting
  Asthma
  
• Immune Dysregulation in Children and Adults with Asthma
  ClinicalTrials.gov Identifier: NCT00135681 - Completed
  Asthma; Lung Diseases
  
• Immune Function of Infants with HIV
  ClinicalTrials.gov Identifier: NCT00073229 - Recruiting
  HIV Infections
  
• Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  ClinicalTrials.gov Identifier: NCT00220740 - Completed
  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  
• Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00220779 - Completed
  Multiple Sclerosis, Relapsing-Remitting
  
• Immune Indicators of Uveitis
  ClinicalTrials.gov Identifier: NCT00089739 - Recruiting
  GITR; GITR Ligand; Uveitis; Immunosuppression; Suppressor of Cytokine Secretion
  
• Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines.
  ClinicalTrials.gov Identifier: NCT00333450 - Completed
  Prophylaxis Pneumococcal Vaccine
  
• Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants
  ClinicalTrials.gov Identifier: NCT00169442 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases
  
• Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.
  ClinicalTrials.gov Identifier: NCT00386659 - Terminated
  HIV Infection
  
• Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00286767 - Recruiting
  HIV Infections
  
• Immune Regulation in Patients with Common Variable Immunodeficiency and Related Syndromes
  ClinicalTrials.gov Identifier: NCT00001244 - Recruiting
  Agammaglobulinemia; Common Variable Immunodeficiency; Immunologic Deficiency Syndrome
  
• Immune Regulation in Ulcerative Colitis or Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00001184 - Recruiting
  Crohn's Disease; Inflammatory Bowel Disease; Ulcerative Colitis
  
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Diphtheria, Tetanus & Pertussis Vaccine (DTaP) Vaccine & a Haemophilus Influenza Type B (Hib) Vaccine in Healthy Children 15 m of Age
  ClinicalTrials.gov Identifier: NCT00197236 - Active, not recruiting
  Hepatitis A
  
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Measles/Mumps/Rubella Vaccine & a Varicella (Chickenpox) Vaccine in Healthy Children
  ClinicalTrials.gov Identifier: NCT00197015 - Recruiting
  Hepatitis A
  
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age
  ClinicalTrials.gov Identifier: NCT00197002 - Completed
  Hepatitis A
  
• Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2
  ClinicalTrials.gov Identifier: NCT00363012 - Recruiting
  Breast Cancer
  
• Immune Response on Neoadjuvant Therapy in NSCLC
  ClinicalTrials.gov Identifier: NCT00406302 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Immune Response Regulation in People Infected Concurrently With Malarial and Filarial Parasites
  ClinicalTrials.gov Identifier: NCT00341666 - Active, not recruiting
  Malaria; Filarial Infection
  
• Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients with Acute or Recent HIV Infection
  ClinicalTrials.gov Identifier: NCT00183261 - Active, not recruiting
  HIV Infections
  
• Immune Response to Cytomegalovirus
  ClinicalTrials.gov Identifier: NCT00034437 - Completed
  Cytomegalovirus Infections
  
• Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.
  ClinicalTrials.gov Identifier: NCT00456625 - Recruiting
  Hepatitis B
  
• Immune Response to Hepatitis C Virus
  ClinicalTrials.gov Identifier: NCT00006301 - Recruiting
  Hepatitis C
  
• Immune Response to Hepatitis C Virus
  ClinicalTrials.gov Identifier: NCT00165919 - Recruiting
  Hepatitis C; HIV Infections
  
• Immune Response to Influenza Vaccination
  ClinicalTrials.gov Identifier: NCT00551837 - Recruiting
  Solid Organ Transplantation; Chronic Kidney Disease
  
• Immune Response to Influenza Vaccine in HIV-Infected Individuals
  ClinicalTrials.gov Identifier: NCT00069914 - Completed
  HIV Infections
  
• Immune Response to Mycobacterium Tuberculosis Infection
  ClinicalTrials.gov Identifier: NCT00257907 - Recruiting
  Latent Tuberculosis
  
• Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected Adults
  ClinicalTrials.gov Identifier: NCT00562939 - Recruiting
  HIV Infections
  
• Immune Response to Varicella Vaccination in Children With Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00406081 - Recruiting
  Atopic Dermatitis
  
• Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452
  ClinicalTrials.gov Identifier: NCT00006495 - Completed
  HIV Infections
  
• Immune Responses to Antigens in Non-Infectious Eye Inflammatory Diseases
  ClinicalTrials.gov Identifier: NCT00357071 - Recruiting
  Eye Diseases
  
• Immune Responses to BCG Vaccination in Malawi and the UK
  ClinicalTrials.gov Identifier: NCT00241657 - Completed
  Immunity, Cellular; Hypersensitivity, Delayed Type
  
• Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers
  ClinicalTrials.gov Identifier: NCT00027482 - Recruiting
  Healthy; HIV Infection
  
• Immune Responses to Mycobacterium Tuberculosis
  ClinicalTrials.gov Identifier: NCT00340990 - Recruiting
  Mycobacterium Tuberculosis
  
• Immune Responses to Smallpox Vaccination
  ClinicalTrials.gov Identifier: NCT00325975 - Recruiting
  Smallpox Vaccine
  
• Immune Responses to Two Dose Varivax +/- MMR-II
  ClinicalTrials.gov Identifier: NCT00258726 - Terminated
  Measles; Mumps; Rubella; Varicella
  
• Immune Restoration by Lipoic Acid in AIDS
  ClinicalTrials.gov Identifier: NCT00033176 - Completed
  Acquired Immunodeficiency Syndrome; HIV Infections
  
• Immune Suppression Of Infants Treated With Steroids
  ClinicalTrials.gov Identifier: NCT00433940 - Recruiting
  Hemangioma
  
• Immune System and Gut Abnormalities in Patients with Common Variable Immunodeficiency with and without Gastrointestinal Symptoms
  ClinicalTrials.gov Identifier: NCT00015431 - Recruiting
  Common Variable Immunodeficiency
  
• Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00257127 - Active, not recruiting
  HIV Infections
  
• Immune System Related Kidney Disease
  ClinicalTrials.gov Identifier: NCT00001979 - Recruiting
  Glomerulonephritis; Lupus Nephritis; Membranous Glomerulonephritis; Nephritis; Nephrotic Syndrome
  
• Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load
  ClinicalTrials.gov Identifier: NCT00013663 - Completed
  HIV Infections
  
• Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients
  ClinicalTrials.gov Identifier: NCT00492739 - Recruiting
  Liver Disease; Liver Transplantation; Varicella
  
• Immunity to Human Cholera in Bangladesh
  ClinicalTrials.gov Identifier: NCT00401934 - Recruiting
  Cholera
  
• Immunization Against Tumor Cells in Sezary Syndrome
  ClinicalTrials.gov Identifier: NCT00099593 - Recruiting
  Cutaneous T-Cell Lymphoma; Sezary Syndrome
  
• Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides
  ClinicalTrials.gov Identifier: NCT00365937 - Recruiting
  Melanoma
  
• Immunization of HLA-A201 Patients with Metastatic Melanoma Using a Combination of Immunodominant Peptides from Three Melanoma Antigens, MART-1, GP100 and Tyrosinase
  ClinicalTrials.gov Identifier: NCT00001685 - Completed
  Melanoma; Neoplasm Metastasis
  
• Immunization of Patients with Metastatic Melanoma Using DNA Encoding the GP100 Melanoma Antigen
  ClinicalTrials.gov Identifier: NCT00001692 - Completed
  Melanoma; Neoplasm Metastasis
  
• Immunization of Patients with Metastatic Melanoma Using Immunodominant Peptides from the Tyrosinase Protein, Tyrosinase Related Protein-1 (TRP1), or GP100 Protein
  ClinicalTrials.gov Identifier: NCT00001684 - Completed
  Melanoma; Neoplasm Metastasis
  
• Immunization of Patients with Metastatic Melanoma Using MART-1 and GP100 Peptides Modified to Increase Binding to HLA-0201
  ClinicalTrials.gov Identifier: NCT00001808 - Completed
  Melanoma; Neoplasm Metastasis
  
• Immunization of Patients with Metastatic Melanoma Using Recombinant Fowlpox and Vaccinia Viruses Encoding the Tyrosinase Antigen
  ClinicalTrials.gov Identifier: NCT00001811 - Completed
  Melanoma; Neoplasm Metastasis
  
• Immunization of Patients with Metastatic Melanoma Using Recombinant Fowlpox Virus Encoding a gp100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
  ClinicalTrials.gov Identifier: NCT00001800 - Completed
  Melanoma; Neoplasm Metastasis
  
• Immunization of Patients with Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
  ClinicalTrials.gov Identifier: NCT00001705 - Completed
  Melanoma; Neoplasm Metastasis
  
• Immunization with 8 Peptides Mixed with Adjuvant CpG 7909 in HLA-A2 Patients with Metastatic Cutaneous Melanoma
  ClinicalTrials.gov Identifier: NCT00145158 - Recruiting
  Malignant Melanoma
  
• Immunization With gp100 Protein Vaccine in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00072085 - Completed
  Melanoma (Skin)
  
• Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00292045 - Completed
  Prostate Cancer
  
• Immunization with the MAGE-3.A1 Peptide Mixed with the Adjuvant CpG 7909 in Patients with Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00145145 - Terminated
  Malignant Melanoma
  
• Immuno & Safety Study of GSK Biologicals’ Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs
  ClinicalTrials.gov Identifier: NCT00343915 - Active, not recruiting
  Prophylaxis of Hepatitis B
  
• Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.
  ClinicalTrials.gov Identifier: NCT00316680 - Completed
  Prophylaxis for Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Influenzae Type b Diseases
  
• Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00231712 - Recruiting
  Leukemia; Medulloblastoma
  
• Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients
  ClinicalTrials.gov Identifier: NCT00323557 - Recruiting
  Leukemia
  
• Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients
  ClinicalTrials.gov Identifier: NCT00356616 - Completed
  HIV Infections
  
• Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
  ClinicalTrials.gov Identifier: NCT00179764 - Recruiting
  Tumors; Malignant Melanoma; Hematological Malignancies; Myelogenous Leukemia, Chronic; Leukemia, Lymphoblastic, Acute
  
• Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1)
  ClinicalTrials.gov Identifier: NCT00146432 - Completed
  Septicemia
  
• Immunobiology of Diabetes and Tuberculosis
  ClinicalTrials.gov Identifier: NCT00568854 - Recruiting
  Tuberculosis; Diabetes Mellitus
  
• Immunochemotherapy for Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00226798 - Recruiting
  Adenocarcinoma Clear Cell
  
• Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Relapsed or Refractory Follicular Lymphoma
  ClinicalTrials.gov Identifier: NCT00366275 - Recruiting
  Follicular Lymphoma
  
• Immunocompetency and Nutritive Status in Inpatient Gero-Rehabilitation
  ClinicalTrials.gov Identifier: NCT00105625 - Completed
  Infection; Geriatrics; Rehabilitation
  
• Immunogenecity of Booster Hepatitis B Vaccines in Children After Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00147459 - Recruiting
  Liver Transplantation
  
• Immunogenetic Factors of Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00005184 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Hypertension; Obesity; Diabetes Mellitus; Hypothyroidism
  
• Immunogenetics of Visceral Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00342823 - Recruiting
  Visceral Leishmaniasis
  
• Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.
  ClinicalTrials.gov Identifier: NCT00548171 - Recruiting
  Diphtheria; Tetanus; Pertussis
  
• Immunogenicity & Safety of GSK’s Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules
  ClinicalTrials.gov Identifier: NCT00316147 - Completed
  Healthy; Infant
  
• Immunogen